CMap Candidates
CMap (Connectivity Map) candidates are extracted from CLUE (CMap and LINCS Unified Environment), with detailed information, e.g., perturbagen time and dose, compound structure, targets, SMILES, mechanism of action. Two publicly available gene expression profiles of NAFLD are used to calculate individual connectivity scores and corresponding statistical significances for these candidates.
stats1
stats2
34330 records.
CMap ID | Pert ID | Compound Name | Targets | MoA | Compound Aliases | |
---|---|---|---|---|---|---|
C08404 | BRD-K19033174 | BRD-K19033174 | -- | -- | -- | Details |
C08405 | BRD-K19033697 | BRD-K19033697 | -- | -- | -- | Details |
C08406 | BRD-K19034817 | pacritinib | FLT3; JAK2 | JAK inhibitor; FLT3 inhibitor | -- | Details |
C08407 | BRD-K19036695 | BRD-K19036695 | -- | -- | -- | Details |
C08408 | BRD-K19036853 | BRD-K19036853 | -- | -- | -- | Details |
C08409 | BRD-K19039329 | BRD-K19039329 | -- | -- | -- | Details |
C08410 | BRD-K19039785 | BRD-K19039785 | -- | -- | -- | Details |
C08411 | BRD-K19040732 | BRD-K19040732 | -- | -- | -- | Details |
C08412 | BRD-K19040998 | BRD-K19040998 | -- | -- | -- | Details |
C08413 | BRD-K19042305 | BRD-K19042305 | -- | -- | -- | Details |
C08414 | BRD-K19042873 | BRD-K19042873 | -- | -- | -- | Details |
C08415 | BRD-K19045069 | BRD-K19045069 | -- | -- | -- | Details |
C08416 | BRD-K19046167 | BRD-K19046167 | -- | -- | -- | Details |
C08417 | BRD-K19048219 | BRD-K19048219 | -- | -- | -- | Details |
C08418 | BRD-K19049172 | ST-4070043 | -- | -- | -- | Details |
C08419 | BRD-K19054042 | BRD-K19054042 | -- | -- | -- | Details |
C08420 | BRD-K19054197 | BRD-K19054197 | -- | -- | -- | Details |
C08421 | BRD-K19056367 | BRD-K19056367 | -- | -- | -- | Details |
C08422 | BRD-K19056919 | BRD-K19056919 | -- | -- | -- | Details |
C08423 | BRD-K19059335 | BRD-K19059335 | RUNX1 | Runt-related transcription factor inhibitor | -- | Details |
C08424 | BRD-K19061245 | BRD-K19061245 | -- | -- | -- | Details |
C08425 | BRD-K19061412 | mubritinib | ERBB2 | Receptor tyrosine protein kinase inhibitor | -- | Details |
C08426 | BRD-K19066553 | BRD-K19066553 | -- | -- | -- | Details |
C08427 | BRD-K19073426 | BRD-K19073426 | -- | -- | -- | Details |
C08428 | BRD-K19084671 | BRD-K19084671 | -- | -- | -- | Details |
C08429 | BRD-K19085288 | BRD-K19085288 | -- | -- | -- | Details |
C08430 | BRD-K19085898 | darapladib | PLA2G7 | Phospholipase inhibitor | -- | Details |
C08431 | BRD-K19089958 | BRD-K19089958 | -- | -- | -- | Details |
C08432 | BRD-K19100834 | BRD-K19100834 | -- | -- | -- | Details |
C08433 | BRD-K19103068 | BRD-K19103068 | -- | -- | -- | Details |
C08434 | BRD-K19103580 | BRD-K19103580 | -- | -- | -- | Details |
C08435 | BRD-K19105325 | BRD-K19105325 | -- | -- | -- | Details |
C08436 | BRD-K19106401 | BRD-K19106401 | -- | -- | -- | Details |
C08437 | BRD-K19106745 | BRD-K19106745 | -- | -- | -- | Details |
C08438 | BRD-K19107160 | tylosin | -- | -- | -- | Details |
C08439 | BRD-K19108281 | BRD-K19108281 | -- | -- | -- | Details |
C08440 | BRD-K19111024 | clofibric-acid | PPARA | PPAR receptor agonist | -- | Details |
C08441 | BRD-K19112099 | BRD-K19112099 | -- | -- | -- | Details |
C08442 | BRD-K19114016 | BRD-K19114016 | -- | -- | -- | Details |
C08443 | BRD-K19114437 | BRD-K19114437 | -- | -- | -- | Details |
C08444 | BRD-K19117583 | BRD-K19117583 | -- | -- | -- | Details |
C08445 | BRD-K19118372 | BRD-K19118372 | -- | -- | -- | Details |
C08446 | BRD-K19122760 | BRD-K19122760 | -- | -- | -- | Details |
C08447 | BRD-K19131810 | SA-89763 | -- | -- | -- | Details |
C08448 | BRD-K19133474 | BRD-K19133474 | -- | -- | -- | Details |
C08449 | BRD-K19134488 | BRD-K19134488 | -- | -- | -- | Details |
C08450 | BRD-K19136521 | BRD-K19136521 | -- | -- | indirubin-3-monoxime | Details |
C08451 | BRD-K19139070 | BRD-K19139070 | -- | -- | -- | Details |
C08452 | BRD-K19142902 | BRD-K19142902 | -- | -- | -- | Details |
C08453 | BRD-K19146323 | STK-661558 | -- | -- | -- | Details |
C08454 | BRD-K19147748 | BRD-K19147748 | -- | -- | -- | Details |
C08455 | BRD-K19147816 | BRD-K19147816 | -- | -- | -- | Details |
C08456 | BRD-K19159562 | BRD-K19159562 | -- | -- | -- | Details |
C08457 | BRD-K19161227 | BRD-K19161227 | -- | -- | -- | Details |
C08458 | BRD-K19166598 | BRD-K19166598 | -- | -- | -- | Details |
C08459 | BRD-K19167425 | BRD-K19167425 | -- | -- | -- | Details |
C08460 | BRD-K19168437 | BRD-K19168437 | -- | -- | -- | Details |
C08461 | BRD-K19171642 | CP-91149 | PYGL | Glycogen phosphorylase inhibitor | -- | Details |
C08462 | BRD-K19175647 | BRD-K19175647 | -- | -- | -- | Details |
C08463 | BRD-K19181733 | BRD-K19181733 | -- | -- | -- | Details |
C08464 | BRD-K19183365 | BRD-K19183365 | -- | -- | -- | Details |
C08465 | BRD-K19189563 | BRD-K19189563 | -- | -- | -- | Details |
C08466 | BRD-K19189705 | BRD-K19189705 | -- | -- | -- | Details |
C08467 | BRD-K19190776 | BRD-K19190776 | -- | -- | -- | Details |
C08468 | BRD-K19194092 | BRD-K19194092 | -- | -- | -- | Details |
C08469 | BRD-K19196783 | BRD-K19196783 | -- | -- | -- | Details |
C08470 | BRD-K19198293 | BRD-K19198293 | -- | -- | -- | Details |
C08471 | BRD-K19203487 | SPP-301 | -- | -- | avosentan | Details |
C08472 | BRD-K19203541 | BRD-K19203541 | -- | -- | -- | Details |
C08473 | BRD-K19203549 | BRD-K19203549 | -- | -- | -- | Details |
C08474 | BRD-K19204484 | BRD-K19204484 | -- | -- | -- | Details |
C08475 | BRD-K19213530 | BRD-K19213530 | -- | -- | -- | Details |
C08476 | BRD-K19216856 | BRD-K19216856 | -- | -- | epigallocatechin | Details |
C08477 | BRD-K19220233 | JNK-9L | MAPK8 | JNK inhibitor | -- | Details |
C08478 | BRD-K19221722 | 5-METHYLCHRYSENE | -- | -- | -- | Details |
C08479 | BRD-K19223413 | BRD-K19223413 | -- | -- | -- | Details |
C08480 | BRD-K19225848 | BRD-K19225848 | -- | -- | -- | Details |
C08481 | BRD-K19227646 | BRD-K19227646 | -- | -- | -- | Details |
C08482 | BRD-K19227686 | phenolphthalein | -- | -- | -- | Details |
C08483 | BRD-K19231873 | BRD-K19231873 | -- | -- | -- | Details |
C08484 | BRD-K19232452 | BRD-K19232452 | -- | -- | -- | Details |
C08485 | BRD-K19234078 | BRD-K19234078 | -- | -- | -- | Details |
C08486 | BRD-K19237647 | BRD-K19237647 | -- | -- | -- | Details |
C08487 | BRD-K19237705 | BRD-K19237705 | -- | -- | -- | Details |
C08488 | BRD-K19245310 | BRD-K19245310 | -- | -- | -- | Details |
C08489 | BRD-K19251038 | BRD-K19251038 | -- | -- | -- | Details |
C08490 | BRD-K19264579 | BRD-K19264579 | -- | -- | -- | Details |
C08491 | BRD-K19266588 | BRD-K19266588 | -- | -- | -- | Details |
C08492 | BRD-K19268781 | BRD-K19268781 | -- | -- | -- | Details |
C08493 | BRD-K19269952 | BRD-K19269952 | -- | -- | -- | Details |
C08494 | BRD-K19272295 | BRD-K19272295 | -- | -- | -- | Details |
C08495 | BRD-K19275171 | BRD-K19275171 | -- | -- | -- | Details |
C08496 | BRD-K19277754 | paroxetine | SLC6A4 | Selective serotonin reuptake inhibitor | -- | Details |
C08497 | BRD-K19284129 | salvinorin-a | OPRK1 | Opioid receptor agonist | -- | Details |
C08498 | BRD-K19288011 | BRD-K19288011 | -- | -- | -- | Details |
C08499 | BRD-K19290969 | BRD-K19290969 | -- | -- | -- | Details |
C08500 | BRD-K19294102 | BRD-K19294102 | -- | -- | -- | Details |
C08501 | BRD-K19295594 | gossypol | MCL1; BCL2; BCL2L1 | BCL inhibitor; MCL1 inhibitor | -- | Details |
C08502 | BRD-K19300944 | MW-STK33-2C | -- | -- | -- | Details |
C08503 | BRD-K19302998 | BRD-K19302998 | -- | -- | -- | Details |